Merck is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to diversify its pipeline. trib.al/9Sdip39

At an ASCO 2024 event, Richard Pazdur, the FDA's top oncologist, said the agency wants to see companies conducting studies across the world, not solely in China. trib.al/hCbJojS

Health insurers are telling shareholders that their AI models can increase efficiency and “cut costs.' But they're not describing how. trib.al/0ftGofd

“How do we continue to prioritize health in Black communities? What do we need to do? That’s a really complicated question.'

New obesity drugs are seemingly everywhere but Black Americans feel left out. trib.al/Ti7LjC0

The people that STAT and Word In Black spoke to for this story shared their journey with weight loss, and their encounters with family and a medical system rooted in anti-Blackness. trib.al/AIzaFyb

ASCO 2024: Corbus, reporting on early trials of its antibody-drug conjugate, says it 'seems to be clinically effective in bladder cancer.' trib.al/S0U32VP

Patients have all sorts of reasons for avoiding cancer screening. At ASCO 2024, researchers report that a conversational AI was surprisingly effective in helping patients navigate those concerns and go… trib.al/JkSCltn

An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway disease in a Phase 3 trial. trib.al/ppmR0vX

Merus said the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer. trib.al/IdOj9tB

Just as we wouldn't compare an oncology drug to an eye drop, it is far-reaching to assume that all prescription digital therapeutics are the same. trib.al/fS8m18b

Do deaf people want a ‘cure’? trib.al/AVT35Lc

Coercive Care Part 2: The doctor would treat her sickle cell pain crisis — if she promised not to get an abortion. trib.al/P64qakA

Join us on June 4 for a STAT Business Look Ahead conversation about the 2024 #STATSummit . How can your brand get the most out of presence at this event?

Register for the conversation: trib.al/0eYF2gC

Will the rescheduling of marijuana help researchers finally get to the bottom of basic questions about cannabis? Will cannabis research finally get cheaper?

Nicholas Florko and Sarah Owermohle have answers. trib.al/MqlHBhu

The federal agency's clarification means hospitals, doctors and other providers don't have to track down and inform millions of patients. trib.al/TNtMd2e

In recent years, federal agencies have quietly welcomed drug treatments that focus on simply reducing use and not necessarily total abstinence. trib.al/KrjlkzX